SCADD Lebanon Pines

Residential Program

37 Camp Mooween Road, Lebanon, CT 06249

SCADD Lebanon Pines Residential Program is an outpatient and residential facility in Lebanon, CT offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment and Medicaid.

Licenses and accreditations

Drug Enforcement Agency (DEA)Registered with the Drug Enforcement Administration.
State department of healthLicensed by the state's department of health.
State mental health departmentLicensed by the state's mental health department.
State substance use treatment agencyLicensed by the state's substance use treatment agency.

Kinds of care

Substance use treatment: Treatment for alcohol and drug use.

Settings

Long-term residential: Living at the facility for more than 30 days.
Outpatient: Regular appointments while living at home.
Outpatient methadone/buprenorphine or naltrexone treatment: Methadone, buprenorphine, or naltrexone for opioid use, with counseling, without staying overnight.
Residential/24-hour residential: Living at the facility during treatment.

Medications for opioid use

Buprenorphine used in Treatment: Buprenorphine is used here.
Naltrexone used in Treatment: Naltrexone is used here.

Accepts clients using MAT but prescribed elsewhere: Accepts clients whose medication for opioid use is prescribed elsewhere.
Buprenorphine maintenance: Buprenorphine continued over time to prevent relapse.
Lofexidine or Clonidine detoxification: Lofexidine or clonidine to ease withdrawal during detox.
Prescribes buprenorphine: Prescribes buprenorphine.
Prescribes naltrexone: Prescribes naltrexone.
Relapse prevention with naltrexone: Naltrexone to help prevent relapse.

Payment

Accepted: Cash or self-payment; Federal, state, or local government funding for substance use treatment; Medicaid.

Who they serve

Ages served: Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
Sex: Male.
Programs for: Adult men.

More details this facility reports

External Opioid Medications Source: In-network prescribing entity.
Type of Alcohol Use Disorder Treatment: This facility administers/prescribes medication for alcohol use disorder.
Pharmacotherapies: Buprenorphine with naloxone; Clonidine; Medication for mental disorders; Naltrexone (oral); Nicotine replacement.
Treatment Approaches: 12-step facilitation; Brief intervention; Motivational interviewing; Relapse prevention; Substance use disorder counseling.
Facility Operation (e.g., Private, Public): Private non-profit organization.
Assessment/Pre-treatment: Comprehensive substance use assessment; Screening for mental disorders; Screening for substance use; Screening for tobacco use.
Testing: Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening; Testing for Hepatitis C (HCV).
Transitional Services: Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge.
Recovery Support Services: Assistance with obtaining social services; Employment counseling or training; Housing services; Mentoring/peer support; Recovery coach; Self-help groups.
Education and Counseling Services: Group counseling; Health education services other than HIV/AIDS or hepatitis; Hepatitis education, counseling, or support; Individual counseling; Smoking/vaping/tobacco cessation counseling; Substance use disorder education; Vocational training or educational support (for example, high school coursework, GED preparation, etc.).
Facility Smoking Policy: Smoking permitted in designated area.
Facility Vaping Policy: Vaping not permitted.
Ancillary Services: Case management service; Integrated primary care services; Mental health services; Social skills development; Suicide prevention services; Transportation assistance.

Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.